Friedrich Maritsch

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema

M. Kunschak, Werner Engl, Friedrich Maritsch et al. · Transfusion · 1998 · 144 citations

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN®: Results of two large phase 3 clinical studies

Alexandra Loew-Baselli, Ryszard Konior, Borislava G. Pavlova et al. · Vaccine · 2006 · 74 citations

Vaccination, Vaccine Safety, Vaccine Development +9

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

Hartmut J. Ehrlich, Borislava G. Pavlova, Sandor Fritsch et al. · Vaccine · 2003 · 58 citations

Vaccination, Vaccine Safety, Vaccine Development +8

A Cell Culture (Vero)–Derived H5N1 Whole‐Virus Vaccine Induces Cross‐Reactive Memory Responses

Hartmut J. Ehrlich, Markus Müller, Sandor Fritsch et al. · The Journal of Infectious Diseases · 2009 · 50 citations · Full text

Comparison of immunogenicity and safety between two paediatric TBE vaccines

Borislava G. Pavlova, Alexandra Löw‐Baselli, Sandor Fritsch et al. · Vaccine · 2010 · 43 citations

Vaccination, Vaccine Safety, Vaccinology +11